StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$63.65−0.23 (-0.36%)

Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –

Eton Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Eton Pharmaceuticals's EV/EBITDA was 92.8× on Nov 11, 2026, against 606.5× a year earlier. Over the last 2 years it ranged from 26.1× to 635.5×, with a median of 161.5×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202692.8×−542.6
2025Dec 31, 2025635.5×+580.2
2024Jul 31, 202455.2×+21.1
2023Dec 29, 202334.1×–

More Eton Pharmaceuticals figures

See a number that looks wrong?